Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Chitogenx Inc C.CHGX

Alternate Symbol(s):  CHNXF

ChitogenX Inc. is a Canada-based emerging orthopedic and sports medicine biologics company. The Company is engaged in the development of therapeutic soft tissue repair technologies to improve the success rate of orthopedic and sports medicine surgeries. The Company’s proprietary biopolymer has been specifically designed to increase the healing rates of occupational and sports related injuries... see more

Recent & Breaking News (CSE:CHGX)

Ortho Regenerative Technologies Enters Into Licensing Agreement to Expand the Scope of its Technological Platform Applications

Canada NewsWire May 20, 2020

Ortho Regenerative Technologies advances ORTHO-R regulatory and clinical projects with $1.1 million private placement

Canada NewsWire April 22, 2020

Ortho Regenerative Technologies Announces Positive Results from Pivotal Preclinical Study in Rotator Cuff Tear Repair

Canada NewsWire March 12, 2020

Ortho Regenerative Technologies Reports its Third Quarter 2020 Financial Results

Canada NewsWire December 31, 2019

Ortho Regenerative Technologies Announces Non-Brokered Private Placement of Convertible Debenture Units

Canada NewsWire December 30, 2019

Ortho RTI Announces Extension of Certain Early Warrants

Canada NewsWire December 12, 2019

Ortho Regenerative Technologies Closes $1.6 Million Private Placement

Canada NewsWire October 9, 2019

Ortho Regenerative Technologies Reports Its Second Quarter 2020 Financial Results

Canada NewsWire October 1, 2019

Ortho RTi Announces Extension of Certain Early Warrants

Canada NewsWire September 17, 2019

Ortho Regenerative Technologies selects US based specialized CRO, MCRA LLC, for its upcoming phase I/II rotator cuff human trial

Canada NewsWire September 12, 2019

ORTHO REGENERATIVE TECHNOLOGIES to Present at the Fall Investor Summit on September 17, 2019 in New York City

Accesswire September 10, 2019

Ortho Regenerative Technologies announces collaborative agreement with leading global Orthopaedic Company

Canada NewsWire August 28, 2019

Ortho Regenerative Technologies Provides Business Update on its Ortho-R Rotator Cuff Program

Canada NewsWire August 14, 2019

Ortho RTi Announces Extension of Certain Early Warrants

Canada NewsWire August 5, 2019

Ortho Regenerative Technologies reports its first quarter 2020 financial results and announces non-brokered private placement

Canada NewsWire July 3, 2019

Ortho Regenerative Technologies Appoints Pierre Laurin to its Board of Directors

Canada NewsWire June 20, 2019

Ortho Regenerative Technologies Announces Changes in Executive Leadership

Canada NewsWire June 17, 2019

Ortho RTi Announces Extension of Certain Early Warrants

Canada NewsWire April 25, 2019

Ortho Regenerative Technologies Announces the Issuance of 1,810,000 Units Pursuant to its Non-Brokered Private Placement

Canada NewsWire October 31, 2017

Ortho Regenerative Technologies Announces Private Placement

Canada NewsWire October 27, 2017